---
title: How I Treat Challenging Transfusion Cases in Sickle Cell Disease
date: '2024-05-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38728382/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240511181524&v=2.18.0.post9+e462414
source: Blood
description: Transfusion of red blood cells (RBCs) can be lifesaving for individuals
  living with sickle cell disease (SCD). However, alloimmunization following transfusion
  is more common with SCD than other patient populations, resulting in morbidity and
  mortality. Management of complications related to RBC alloantibodies, including
  delayed hemolytic transfusion reactions (DHTRs) and identifying compatible RBCs
  for future transfusions, remains a challenge for hematologists and transfusion medicine
  ...
disable_comments: true
---
Transfusion of red blood cells (RBCs) can be lifesaving for individuals living with sickle cell disease (SCD). However, alloimmunization following transfusion is more common with SCD than other patient populations, resulting in morbidity and mortality. Management of complications related to RBC alloantibodies, including delayed hemolytic transfusion reactions (DHTRs) and identifying compatible RBCs for future transfusions, remains a challenge for hematologists and transfusion medicine ...